ctured from human amniotic membrane. The Company has an experienced team poised to capitalize on its science and technology to generate rapid sales growth and profitability. Our mantra is "Repair, don't replace" because our biochemists, engineers, designers and physicians believe it is better to augment repair when possible rather than replace traumatized, but otherwise healthy tissues and structures. Our platform technologies, HydroFix™ and CollaFix™, and our newest platform technology, Purion® developed by our wholly-owned subsidiary, Surgical Biologics, have a vast number of potential applications in treating traumatized tissue and structures and MiMedx is focused on commercializing multiple applications for the Company's three technology platforms. In parallel, we are seeking strategic relationships, in selective categories, to more rapidly commercialize our technologies.
*Earnings before interest, taxes, depreciation, amortization and share based compensation is a non-GAAP financial measure and should not be considered a replacement for GAAP results. For a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure, see accompanying table to this release.
Safe Harbor StatementThis press release includes statements that look forward in time or that express management's beliefs, expectations or hopes. Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the expected decline during the balance of the fiscal year in one-time acquisition costs and expenses related to investments in animal studies, the Company's revenue expectations for the month of April, the Company's anticipated revenue opportunity in the wound care market, the timing of revenue from the Company's EpiFix™ wound care tissue and the anticipated Page: 1 2 3 4 5 6 7 Related biology technology :1
. MiMedx Group Announces Temporary Trading Symbol Designation2
. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference3
. MiMedx Group, Inc. Announces Release Date For Third Quarter Results4
. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference5
. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting6
. MiMedx Announces Launch of AmnioFix™7
. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference8
. MiMedx Group Announces 2010 Results9
. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice10
. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results11
. China Bio Energy Holdings Group Reports Second Quarter 2008 Financial Results